십이지장 내시경 시장 규모, 점유율, 성장 및 세계 업계 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of duodenoscopes Market

The global duodenoscopes market size was valued at USD 1.08 billion in 2025. The market is projected to grow from USD 1.16 billion in 2026 to USD 2.22 billion by 2034, exhibiting a CAGR of 8.4% during the 2026-2034 forecast period. North America dominated the market with a 37.04% share in 2025, reaching a regional market value of approximately USD 0.40 billion.

Duodenoscopes are specialized flexible endoscopes primarily used during Endoscopic Retrograde Cholangiopancreatography (ERCP) procedures to diagnose and treat conditions affecting the bile duct, pancreatic duct, duodenum, and papilla. Rising cases of biliary disorders, pancreatic diseases, gallstones, strictures, tumors, and gastrointestinal conditions are supporting market expansion.

Duodenoscopes Market Trends

Hybrid Safety Designs Gain Market Attention

A major trend in the market is the transition from conventional reusable duodenoscopes toward hybrid safety models. These include reusable scopes with disposable distal caps, fully single-use devices, and reusable scopes compatible with advanced sterilization systems. Hospitals are increasingly prioritizing sterility assurance, easier cleaning, improved distal-end access, disposable components, and simplified reprocessing workflows. This shift is also encouraging manufacturers to compete on infection prevention and sustainability in addition to image quality and handling.

Market Drivers

Rising ERCP Procedures Support Market Growth

Increasing demand for ERCP procedures is one of the primary market drivers. ERCP is widely used to treat gallstones, pancreaticobiliary strictures, tumors, pancreatitis complications, and bile duct obstructions. The procedure has increasingly shifted from diagnostic use toward therapeutic interventions such as stone extraction, stent placement, sphincterotomy, and drainage.

Growing infection-control awareness is also driving demand for disposable components, validated sterilization processes, and single-use duodenoscopes.

Market Restraints

High Cost and Complex Reprocessing Limit Adoption

Reusable duodenoscopes require substantial investment in reprocessing systems, maintenance, trained personnel, storage, repair, and compliance documentation. Although single-use systems reduce contamination concerns, their higher per-procedure costs can restrict adoption among high-volume and price-sensitive healthcare facilities.

Additional costs related to surveillance cultures, scope downtime, staff resources, and infection management also create procurement challenges.

Market Opportunities

Sterile and Single-Use Platforms Create Growth Opportunities

Growing adoption of sterile, disposable, and sterilizable reusable duodenoscopes presents strong opportunities for manufacturers. Single-use devices are particularly useful for urgent procedures, immunocompromised patients, and high-risk cases where contamination concerns are significant. Hospitals are also showing interest in sterilizable reusable solutions that combine familiar clinical performance with improved infection-control assurance.

Market Challenges

Stringent regulations and complex cleaning requirements remain important market challenges. The elevator mechanism and distal end of duodenoscopes can be difficult to clean and validate. Product recalls, regulatory warning letters, staff training requirements, environmental concerns associated with disposable scopes, and reimbursement limitations can also affect purchasing decisions.

Segmentation Analysis

By product type, reusable duodenoscopes held the largest market share in 2025 due to their large installed base and established use across high-volume ERCP centers. However, disposable duodenoscopes are projected to grow at a strong 12.2% CAGR during the forecast period.

By application, the therapeutic segment dominated in 2025, supported by growing use of ERCP for stone extraction, drainage, stenting, stricture dilation, and other pancreaticobiliary procedures. The diagnostic segment is projected to grow at a 6.9% CAGR.

By end-user, hospitals & ASCs held the largest share in 2025 and are expected to account for 84.6% of the market in 2026. Specialty clinics are projected to expand at a 10.6% CAGR.

Regional Outlook

North America dominated with USD 0.40 billion in 2025, compared with USD 0.37 billion in 2024. The U.S. market is projected to reach USD 0.40 billion in 2026, representing around 34.3% of global revenues.

Europe is expected to reach USD 0.34 billion in 2026 and grow at a 7.2% CAGR. Germany and the U.K. are projected to reach approximately USD 0.07 billion and USD 0.05 billion, respectively, in 2026.

Asia Pacific is projected to reach USD 0.32 billion in 2026, making it the third-largest regional market. China, Japan, and India are estimated at approximately USD 0.12 billion, USD 0.11 billion, and USD 0.03 billion, respectively.

Latin America is estimated to reach approximately USD 0.04 billion in 2026, while the GCC market is projected at around USD 0.01 billion.

Competitive Landscape

Major companies include Olympus Corporation, Boston Scientific Corporation, FUJIFILM Holdings Corporation, PENTAX Medical, Ambu A/S, SonoScape Medical Corp, Ottomed, MITRA Industries, and KARL STORZ SE & Co. KG. Olympus, Boston Scientific, and Ambu held prominent positions in 2025 due to strong brand recognition, broad portfolios, innovation, and geographic presence.

Key Industry Developments

In January 2026, ASP announced CE marking for its ULTRA GI Cycle for duodenoscopes in partnership with FUJIFILM Healthcare Europe. During 2025, FUJIFILM expanded its ED-840T duodenoscope, while PENTAX Medical and ASP launched a sterilizable duodenoscope in the U.S. Ambu also expanded its aScope Duodeno 2 platform following regulatory clearances.

Conclusion

The duodenoscopes market is expected to expand steadily as ERCP procedure volumes rise and healthcare providers place greater emphasis on infection prevention and procedural safety. The market increases from USD 1.08 billion in 2025 to USD 1.16 billion in 2026 and is projected to reach USD 2.22 billion by 2034, at a CAGR of 8.4%. Growing adoption of single-use systems, hybrid safety designs, advanced sterilization technologies, and therapeutic ERCP procedures will remain central to market growth through 2034.

Segmentation By Product Type, Application, End-user, and Region

By Product Type

• Reusable
• Disposable

By Application

• Diagnostic
  • Biliary Disorders
  • Pancreatic Disorders
  • Others
• Therapeutic
  • Stone Removal
  • Stent Placement
  • Sphincterotomy
  • Others

By End-user

• Hospitals & ASCs
• Specialty Clinics
• Others

By Region

• North America (By Product Type, Application, End-user, and Country)
  • U.S. (Product Type)
  • Canada (Product Type)
• Europe (By Product Type, Application, End-user, and Country/Sub-region)
  • Germany (Product Type)
  • U.K. (Product Type)
  • France (Product Type)
  • Spain (Product Type)
  • Italy (Product Type)
  • Scandinavia (Product Type)
  • Rest of Europe (Product Type)
• Asia Pacific (By Product Type, Application, End-user, and Country/Sub-region)
  • China (Product Type)
  • Japan (Product Type)
  • India (Product Type)
  • Australia (Product Type)
  • Southeast Asia (Product Type)
  • Rest of Asia Pacific (Product Type)
• Latin America (By Product Type, Application, End-user, and Country/Sub-region)
  • Brazil (Product Type)
  • Mexico (Product Type)
  • Rest of Latin America (Product Type)
• Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-region)
  • GCC (Product Type)
  • South Africa (Product Type)
  • Rest of Middle East & Africa (Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Challenges
• 3.5. Market Trends

4. Key Insights

• 4.1. Prevalence/Incidence of Key Conditions, By Key Countries/Region, 2025
• 4.2. Number of Key Procedures, By Key Countries/Region, 2025
• 4.3. Advancements in Duodenoscopes
• 4.4. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)

5. Global Duodenoscopes Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Reusable
  • 5.1.2. Disposable
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Diagnostic
    • 5.2.1.1. Biliary Disorders
    • 5.2.1.2. Pancreatic Disorders
    • 5.2.1.3. Others
  • 5.2.2. Therapeutic
    • 5.2.2.1. Stone Removal
    • 5.2.2.2. Stent Placement
    • 5.2.2.3. Sphincterotomy
    • 5.2.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospitals & ASCs
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Duodenoscopes Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Reusable
  • 6.1.2. Disposable
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Diagnostic
    • 6.2.1.1. Biliary Disorders
    • 6.2.1.2. Pancreatic Disorders
    • 6.2.1.3. Others
  • 6.2.2. Therapeutic
    • 6.2.2.1. Stone Removal
    • 6.2.2.2. Stent Placement
    • 6.2.2.3. Sphincterotomy
    • 6.2.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospitals & ASCs
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. By Product Type
  • 6.4.2. Canada
    • 6.4.2.1. By Product Type

7. Europe Duodenoscopes Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Reusable
  • 7.1.2. Disposable
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Diagnostic
    • 7.2.1.1. Biliary Disorders
    • 7.2.1.2. Pancreatic Disorders
    • 7.2.1.3. Others
  • 7.2.2. Therapeutic
    • 7.2.2.1. Stone Removal
    • 7.2.2.2. Stent Placement
    • 7.2.2.3. Sphincterotomy
    • 7.2.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospitals & ASCs
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. Germany
    • 7.4.1.1. By Product Type
  • 7.4.2. U.K.
    • 7.4.2.1. By Product Type
  • 7.4.3. France
    • 7.4.3.1. By Product Type
  • 7.4.4. Italy
    • 7.4.4.1. By Product Type
  • 7.4.5. Spain
    • 7.4.5.1. By Product Type
  • 7.4.6. Scandinavia
    • 7.4.6.1. By Product Type
  • 7.4.7. Rest of Europe
    • 7.4.7.1. By Product Type

8. Asia Pacific Duodenoscopes Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Reusable
  • 8.1.2. Disposable
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Diagnostic
    • 8.2.1.1. Biliary Disorders
    • 8.2.1.2. Pancreatic Disorders
    • 8.2.1.3. Others
  • 8.2.2. Therapeutic
    • 8.2.2.1. Stone Removal
    • 8.2.2.2. Stent Placement
    • 8.2.2.3. Sphincterotomy
    • 8.2.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospitals & ASCs
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. China
    • 8.4.1.1. By Product Type
  • 8.4.2. India
    • 8.4.2.1. By Product Type
  • 8.4.3. Japan
    • 8.4.3.1. By Product Type
  • 8.4.4. Australia
    • 8.4.4.1. By Product Type
  • 8.4.5. Southeast Asia
    • 8.4.5.1. By Product Type
  • 8.4.6. Rest of Asia Pacific
    • 8.4.6.1. By Product Type

9. Latin America Duodenoscopes Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Reusable
  • 9.1.2. Disposable
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Diagnostic
    • 9.2.1.1. Biliary Disorders
    • 9.2.1.2. Pancreatic Disorders
    • 9.2.1.3. Others
  • 9.2.2. Therapeutic
    • 9.2.2.1. Stone Removal
    • 9.2.2.2. Stent Placement
    • 9.2.2.3. Sphincterotomy
    • 9.2.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospitals & ASCs
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
    • 9.4.1.1. By Product Type
  • 9.4.2. Mexico
    • 9.4.2.1. By Product Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. By Product Type

10. Middle East & Africa Duodenoscopes Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Reusable
  • 10.1.2. Disposable
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Diagnostic
    • 10.2.1.1. Biliary Disorders
    • 10.2.1.2. Pancreatic Disorders
    • 10.2.1.3. Others
  • 10.2.2. Therapeutic
    • 10.2.2.1. Stone Removal
    • 10.2.2.2. Stent Placement
    • 10.2.2.3. Sphincterotomy
    • 10.2.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospitals & ASCs
  • 10.3.2. Specialty Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. South Africa
    • 10.4.1.1. By Product Type
  • 10.4.2. GCC
    • 10.4.2.1. By Product Type
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By Product Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Olympus Corporation
  • 11.2.2. Boston Scientific Corporation
  • 11.2.3. FUJIFILM Holdings Corporation
  • 11.2.4. PENTAX Medical
  • 11.2.5. Ambu A/S
  • 11.2.6. SonoScape Medical Corp
  • 11.2.7. Ottomed
  • 11.2.8. MITRA Industries
  • 11.2.9. KARL STORZ SE & Co. KG